C-JXSCIchor Life Sciences
CRO services, drug discovery, preclinical pharmacology
research tools
Loading
Загрузка раздела...0-100 chain-logic scale · 15 dimensions · scored on public evidence
All companiesC-JXSC
C-JXSCC-JXSCCRO services, drug discovery, preclinical pharmacology
0-100 chain-logic scale · 15 dimensions · scored on public evidence
The Phase I study will assess the basic safety, tolerability, and immunogenicity of a DNA-based Venezuelan equine encephalitis virus (VEEV)vaccine candidate delivered by electroporation . The study will enroll 40 healthy adult volunteers ages 18-49 and will comprise evaluation of intradermal or intramuscular administration by electroporation. Administration of the vaccine candidate will be at two DNA dose levels (0.5 mg/ml and 2.0 mg/ml) for each route of administration. Electroporation will be administered using the TriGrid Delivery System devices for intramuscular and intradermal delivery. An additional group of subjects will serve as a placebo control, receiving injections of saline with electroporation. The overall goal of this study will be to determine if further human clinical studies of the vaccine candidate are warranted and, if so, to aid in the selection of dose and route of administration for future studies.
The purpose of this study is to evaluate the safety and immunogenicity of a DNA vaccine encoding a melanosomal antigen in melanoma patients at risk for disease progression or recurrence. In this study, the vaccine will be administered intramuscularly using a device that applies brief electrical fields to the tissue at the site of injection (a technique known as electroporation). It is expected that this device will improve the delivery of the vaccine. This study is being performed to determine if this procedure can be administered safely and if it is capable of inducing immune responses to the vaccine.
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Electroporation therapy may enhance the ability of chemotherapy drugs to enter tumor cells. Combining chemotherapy with electroporation therapy may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of electroporation therapy and bleomycin in treating patients who have locally advanced pancreatic cancer.
Ichor Therapeutics Rebrands as Ichor Life Sciences, Focuses on Contract Research Work and Strategic Programs - Ichor Life Sciences Skip to content Services Protein Services Protein Expression & Purification Services Adeno-Associated Virus (AAV) Structural Biology Services X-Ray Crystallography Services Biophysical Assays Surface Plasmon Resonance Services Biacore Assay Services Circular Dichroism (CD) Assay Services nanoDSF Assay Services Bio-layer Interferometry Services Isothermal Titration Calorimetry Plate-Based Assay Services View All Protein Services Pharmacology Services Drug Disco
Ichor Inc. - Kitchener - Ontario - Canada - Jaclyn - Eventeny Skip to content or footer Organize Event Management Tools Event mapping Ticketing / registration Artist, vendor & exhibitor management Volunteer management Sponsor management Event programming & talent management - New Interactive schedules Hardware solutions Mobile app for organizers - New Solutions by event type About Eventeny Product overview Company values Pricing Helpful Resources Knowledge base Community center Comparison guide Blog Contact sales Product updates Case studies See all events Create an Event Participate Artis … keting text messages. Reply STOP to cancel, HELP for help. Msg & data rates may apply. Newsletter coming soon. In the meantime, browse new events. Subscribe Go to participant sign-up Browse events Eventeny was founded on the belief that managing large-scale events with hundreds of exhibitors, vendors, sponsors, and volunteers should not be stressful and burdensome. Our mission is to remove event organizers from being the 5th most stressful job in the world. That's why we buil
Ichor Holdings, Ltd. (ICHR) 10-Q Quarterly Report May 2026 HOME LOGIN PREMIUM SEC FILINGS FREE TRIAL API FOOTNOTED STOCK SCREENERS EARNINGS TRENDING INSIDER TRADING MANAGER PORTFOLIOS SENTIMENT ANALYSIS LATE NT SEC FILINGS Ichor Holdings, Ltd. (ICHR) SEC Filing 10-Q Quarterly Report for the period ending Friday, March 27, 2026 Home SEC Filings Ichor Holdings, Ltd. (ICHR) 10-Q Quarterly Report Tue May 05 2026 SEC Filings ICHR Valuations Intrinsic Value Financial Stability Financial Ratios Insider Trades Manager Portfolios Historical Financials (CSV) Notifications ICHR Annual Reports 10-K … ese statements also relate to... Read more Financial - Cash Flow Our ability to fund these... Read more Financial - Expense The decrease in research and... Read more Financial - Expense The change in other expense,... Read more Financial - Expense Outsourcing enables OEMs to reduce... Read more Other - Other The period‑to‑period comparison of results... Read more Financial Statements, Disclosures and Schedules Inside this 10-Q Quarterly Report Cover Consolidated Balance Sheet
Ichor Announces Participation in 14th Annual CEO Summit Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Markets Stocks ETFs Tools Markets: Overview News Currencies International Treasuries Ichor Announces Participation in 14th Annual CEO Summit By: Ichor Holdings, Ltd. via Business Wire June 21, 2022 at 09:00 AM EDT ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. Ichor Holdings, Ltd. ( NASDAQ: ICHR ), a leader in the design, engi
Ichor files $200M at-the-market shelf offering | ICHR Prospectus Summary --> STOCK TITAN Login Sign up Login Sign up 0 HOME --> NEWS FEED Stock News Live Stock News Today Trending News AI news FDA Approvals Clinical Trials Crypto News Merger & Acquisitions Earnings Offerings IPO News Stock Splits Top News - Gainers Top News - Losers SEC FILINGS SEC Filings Live SEC Filings Today Form 4 - Insider Trading 8-K - Material Events 10-K - Annual Reports 10-Q - Quarterly Reports DEF 14A - Proxy Statements S-1 - IPO Registration S-3 - Shelf Registration STOCKS All Stock Themes AI Stocks Crypto Stocks O … Holdings (NASDAQ: ORBS) Reports Total Holdings of Approxi... DLHC DLH Contract Award Opens New Growth Channels with U.S Navy RKLB NASA Selects Rocket Lab to Launch Sun, Earth Sciences Missions SHPH United Dogecoin Advances Data Centre and Power Infrastructure Str... ON onsemi to Acquire Synaptics to Enable the Next Generation of Inte... ILLR Triller Group (Nasdaq: ILLR): The Reverse Split Is Not the Story ... BMNR ORBS Eightco Holdings (NASDAQ: ORBS) Reports Total Holdings o … Holdings (NASDAQ: ORBS) Reports Total Holdings of Approxi... DLHC DLH Contract Award Opens New Growth Channels with U.S Navy Previous Next --> Overview Financials News SEC Filings Ichor (NASDAQ: ICHR) files $200M ATM shelf to repay debt, fund growth Filing Impact (Neutral) Filing Sentiment (Neutral) Form Type 424B5 Rhea-AI Filing Summary English Italian Spanish German Korean French Arabic Ichor Holdings, Ltd. proposes an at-the-market offering of up to $200,000,000 of ordina … spectus estimates net proceeds of $199.3 million and specifically notes planned application toward repayment of the term loan principal of $123.4 million (maturing September 26, 2030) and for capital expenditures, acquisitions and other corporate needs. The company retains discretion over final allocation. Investors should note the net-proceeds estimate, the stated agent commission up to 3.0%, and the potential for variable daily volumes and prices inherent in an ATM program; … tion about the securities we may offer from time to time, some of which may not apply to this offering. Generally, when we refer to this prospectus, we are referring to both parts of this document combined. To the extent there is a conflict between the information contained in this prospectus supplement, on the one hand, and the information conta
Francisco Partners Acquires Ichor Systems | Media | Francisco Partners Skip Navigation About Overview Culture Contact Approach Overview FP Operating Executives* Sustainability Strategies Private Equity Credit and Structured Solutions Team Investments Media PE Login (opens in new window) Credit Login (opens in new window) Back To Media Francisco Partners Acquires Ichor Systems Press Releases — Jan 05, 2012 Team Dipanjan (DJ) Deb Andrew Kowal Status Exited Deal Facts North America Private Buy Out Francisco Partners, a leading technology-focused private equity firm, today announced the acquisitio … 55 Ave. of the Americas 37th Floor New York, NY 10036 +1 (646) 434 1343 Careers Apply for positions within our team (opens in new window) Careers with our portfolio companies (opens in new window) Sitemap Legal Privacy Policy Cookie Policy PE Login (opens in new window) Credit Login (opens in new window) © 2026 Francisco Partners. All Rights Reserved. a FINE site (opens in new window)
Ichor COO has shares withheld for RSU taxes | ICHR Insider Trading --> STOCK TITAN Login Sign up Login Sign up 0 HOME --> NEWS FEED Stock News Live Stock News Today Trending News AI news FDA Approvals Clinical Trials Crypto News Merger & Acquisitions Earnings Offerings IPO News Stock Splits Top News - Gainers Top News - Losers SEC FILINGS SEC Filings Live SEC Filings Today Form 4 - Insider Trading 8-K - Material Events 10-K - Annual Reports 10-Q - Quarterly Reports DEF 14A - Proxy Statements S-1 - IPO Registration S-3 - Shelf Registration STOCKS All Stock Themes AI Stocks Crypto Stocks Oil & G … Holdings (NASDAQ: ORBS) Reports Total Holdings of Approxi... DLHC DLH Contract Award Opens New Growth Channels with U.S Navy RKLB NASA Selects Rocket Lab to Launch Sun, Earth Sciences Missions SHPH United Dogecoin Advances Data Centre and Power Infrastructure Str... ON onsemi to Acquire Synaptics to Enable the Next Generation of Inte... ILLR Triller Group (Nasdaq: ILLR): The Reverse Split Is Not the Story ... BMNR ORBS Eightco Holdings (NASDAQ: ORBS) Reports Total Holdings o … Holdings (NASDAQ: ORBS) Reports Total Holdings of Approxi... DLHC DLH Contract Award Opens New Growth Channels with U.S Navy Previous Next --> Overview Financials News SEC Filings Ichor (ICHR) COO has 2,497 shares withheld for RSU tax obligations Filing Impact (Moderate) Filing Sentiment (Neutral) Form Type 4 Rhea-AI Filing Summary English Italian Spanish German Korean French Arabic Ichor Holdings Chief Operating Officer Bruce Ragsdale reported routine share dispositions rel … ore 5 terms restricted stock unit financial "vesting of a restricted stock unit award" A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees. tax withholding obligations financial "withheld to cover tax withholding … withholding obligations associated with the vesting of a restricted stock unit award. Remarks: /s/ Ryan Barger by Power of Attorney 05/15/2026 ** Signature of Reporting Person Date Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person,
Contract Manufacturing | Ichor Systems JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser. Skip to Content Menu x Product categories Industries Return To Industries Shop By Subcategory Semiconductor Return To Semiconductor Shop By Sub-subcategory General Industrial Return To General Industrial Shop By Sub-subcategory Expertise Return To Expertise Shop By Subcategory Engineering Return To Engineering Shop By Sub-subcategory Manufacturing Return To Manufacturing Shop By Sub-subcategory Design/Build Return To Design/ … s include Milling, Turning, Swiss, Mill-Turn, and 5-Axis covering virtually any application. Our precision machining capabilities are the core to our contract manufacturing offering for your complete solution requirements. At Ichor, we take on the projects that others cannot or will not do. More than Machining Ichor is vertically integrated to provide the turnkey capabilities our customers require. Some of our capabilities beyond machining include: Cleaning – Ultrasonic … first, often gives you the advantage you need to win. Ichor’s experienced Application Engineers can be considered an extension of your Engineering Department for product development support. Ichor's ability to transition from prototype into scaled and sustained production gives you the full-service partner for all your development and production needs. Engineering Services Ichor has extensive engineering resources to support your technical requirements to support protot … e earliest stages of product development. We boast a highly experienced team of Application Engineers accessible to our customer engineers for technical support and have the equipment and knowledge to bring your concepts from ideas to reality. We utilize the most current product engineering services including Design for Manufacturing (DFM), 3-D modeling, finite element analysis (FEA), and more. Ichor’s ability to transition from prototype into scaled and sustained produ
https://lnkd.in/dQVB3M7D"> https://lnkd.in/dQVB3M7D"> https://lnkd.in/dQVB3M7D"> Ichor Announces Acquisition of IMG “IMG brings to Ichor additional precision machining capabilities and capacity, as well as advanced manufacturing capabilities such as e-beam and laser welding… | Ichor Systems, Inc. LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Re
424B5 1 ichor-finalprosupp424b5.htm 424B5 Document Filed Pursuant to Rule 424(b)(5) Registration No. 333-273825 Prospectus Supplement (to Prospectus dated August 9, 2023) 3,333,334 Shares ICHOR HOLDINGS, LTD. Ordinary Shares We are selling 3,333,334 of our ordinary shares, par value $0.0001 per share. Our ordinary shares are listed on The Nasdaq Global Select Market under the symbol “ICHR.” The last reported sale price of our ordinary shares on The Nasdaq Global Select Market on March 12, 2024 was $42.68 per share. Investing in our ordinary shares involves a high degree o … Short-Term Bank Yield Index rate of 7.58%. The precise amount and timing of the application of such proceeds will depend upon our liquidity needs and the availability and cost of other capital over which we have little or no control. As of the date of this prospectus supplement, we cannot specify with certainty the particular uses for the net proceeds that we will have from the sale of our ordinary shares. See “Risk Factors—We will have broad discretion in the use … imposing any tax to be levied on profits, income, gains or appreciations shall apply to us or our operations; and • (b) in addition, that no tax to be levied on profits, income, gains or appreciations or which is in the nature of estate duty or inheritance tax shall be payable. ◦ (i) on or in respect of our shares, debentures or other obligations; or  ◦ (ii) by way of the withholding in whole or part, of any relevant payment as defined in Secti … ent. All of the foregoing authorities are subject to change, which change could apply retroactively and could significantly affect the tax consequences described below. We have not sought any ruling from the IRS with respect to the statements made and the conclusions reached in the following discussion and there can be no assurance that the IRS or a court will agree with our statements and conclusions. This discussion, moreover, does not address the United States federal esta … NNING AND ADVICE. HOLDERS SHOULD CONSULT THEIR TAX ADVISORS WITH RESPECT TO THE APPLICATION OF THE UNITED STATES FEDERAL INCOME TAX LAWS TO THEIR PARTICULAR SITUATIONS, AS WELL AS ANY TAX CONSEQUENCES ARISING UNDER THE UNITED STATES FEDERAL ESTATE OR GIFT TAX LAWS OR THE LAWS OF ANY STATE, LOCAL OR NON-UNITED STATES TAXING JURISDICTION OR UNDER A
XBRL Viewer Please enable JavaScript to use the EDGAR Inline XBRL Viewer.
Ichor - Acquisition of IMG - Headgate Partners Skip to content Menu Menu Home About Claire Areas of Expertise Corporate Finance Semiconductor Industry Strategic Financial Communications & IR Governance, SEC & Shareholder Activism CEO Summit Contact Ichor – Acquisition of IMG Acquisition of IMG © 2026 Headgate Partners
ICHOR HOLDINGS, LTD. (Form: 8-K, Received: 11/28/2022 19:03:44) false 0001652535 00-0000000 0001652535 2022-11-28 2022-11-28   UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549   FORM 8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 28, 2022   ICHOR HOLDINGS, LTD. (Exact name of registrant as specified in its charter)             Cayman Islands   001-37961   Not Applicable (State or other jurisdiction of incor … d Board of Directors. You are being recommended and approved for a new hire RSU grant valued at $1,600,000. The RSU grant date and value is determined on the first of the month, following your start date. The vesting schedule is 25% on year one, then quarterly thereafter, and fully vested in four years. You will be provided a grant agreement within a month of your date of hire, which will come under separate cover. Benefits Your participation in the benefit program
--> 2022 Annual Report - Geneva USA About Geneva About Geneva Board of Directors Scientific Advisory Board Leadership Team FAQ Ethics & Corporate Responsibility Research Programs of Research Autonomous Reanimation and Evacuation (AREVA) Research Institute & Innovation Center Musculoskeletal Injury Rehabilitation Research for Operational Readiness (MIRROR) Research for Combat Casualty Care Operations Network (REC3ON) USU-4D Bio 3 Center for Biotechnology Research Research Focus Areas Oncology CBRNE Medical Countermeasures Combat Casualty Care and Trauma Infectious Diseases Medical Mod … with TSNRP dates to 1996, when we received our first federally funded research grant from TSNRP. Today, we’re proud to serve in a program management role to administer the activities. Geneva continued to expand research solutions through chemical, biological, radiological, nuclear, and explosives (CBNRE) defense-based acquisition lifecycle research. The U.S. Army awarded Geneva and ERP International the U.S. Army Combat Capabilities Development Command, Chemical Biological C … Proposals Total Amount --> --> 1 44 --> 0 Total Proposals Submitted $ 0 M Total Proposal Submission Amount $ 0 M Grant Proposals Submitted ($40.7M Received And Pending) --> $ 0 M 2022 Total Award Revenue Top 10 Research Areas by Funded Amount 30% Infectious Diseases 12% Rehabilitative Medicine 11% Regenerative Medicine 8% Critical Care 8% Evidence Based Practice (EBP) 5% Telemedicine 4% Oncology 4% Neurology 3% Behavioral & Mental Health 3% Orthopedics 30% 12% 11% 8% 8% 5% 4% … e a lasting impact on military and civilian health outcomes. Geneva’s Discovery Fund allows unrestricted donor gifts to be directed towards pressing research initiatives in real time. In 2022, our donors influenced research in wound care, infectious diseases, rehabilitative medicine, and biotechnology. Donation to Geneva Honors Dr. Charles Andersen’s Impact and Wound Care Research In 2023, a generous donor contributed to Geneva’s Discovery Fund in honor of Principal Inv … MORE NOISE Study Team is awarded the Outstanding Research Accomplishment Award by the Military Health System. READ MORE LTC Christopher Stucky, PhD, RN, CNOR, CSSM, NEA-BC, USA is inducted into the American Academy of Nursing 2022 Class of Fellows and named Army Nurse of the Year. READ MORE Dr. Christina La Croix is awarded t
Drug Discovery & Development Services | Ichor Life Sciences Skip to content Services Protein Services Protein Expression & Purification Services Adeno-Associated Virus (AAV) Structural Biology Services X-Ray Crystallography Services Biophysical Assays Surface Plasmon Resonance Services Biacore Assay Services Circular Dichroism (CD) Assay Services nanoDSF Assay Services Bio-layer Interferometry Services Isothermal Titration Calorimetry Plate-Based Assay Services View All Protein Services Pharmacology Services Drug Discovery Services Drug Development Services Lead Discovery Services Lea
Ichor Systems JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser. Skip to Content Menu x Product categories Industries Return To Industries Shop By Subcategory Semiconductor Return To Semiconductor Shop By Sub-subcategory General Industrial Return To General Industrial Shop By Sub-subcategory Expertise Return To Expertise Shop By Subcategory Engineering Return To Engineering Shop By Sub-subcategory Manufacturing Return To Manufacturing Shop By Sub-subcategory Design/Build Return To Design/Build Shop By Sub-subcate
ichr-8k_20211111.htm false 0001652535 00-0000000 0001652535 2021-11-11 2021-11-11   UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549   FORM 8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 11, 2021   ICHOR HOLDINGS, LTD. (Exact name of registrant as specified in its charter)             Cayman Islands   001-37961   Not Applicable (State or other jurisdiction of incorporation)   (Commission File Number) &
ichr-20241227 0001652535 00-0000000 2024 FY FALSE Large Accelerated Filer P1Y xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure ichr:Segment 0001652535 2023-12-30 2024-12-27 0001652535 2025-02-18 0001652535 2024-06-28 0001652535 2024-09-28 2024-12-27 0001652535 2024-12-27 0001652535 2023-12-29 0001652535 2022-12-31 2023-12-29 0001652535 2022-01-01 2022-12-30 0001652535 us-gaap:CommonStockMember 2021-12-31 0001652535 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001652535 us-gaap:TreasuryStockCommonMember 2021-12-31 0001652535 us-gaap:RetainedEarningsMember 2021-12-31 0001652535 … eding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non‑accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in … o the chemical delivery subsystem, we also manufacture the process modules that apply the various chemicals directly to the wafer in a process-and application-unique manner to create the desired chemical reaction. 5 Table of Contents The image below shows a typical wet-process front end semiconductor tool, with a chemical delivery subsystem and corresponding application process module highlighted: Weldments and Specialty Joining Our complete offering of weldments support the … ommit to minimum purchase volumes. While most of our customers provide periodic rolling forecasts for product orders, those forecasts do not become binding until a formal purchase order is submitted, which generally occurs only a short time prior to shipment. As a result of the foregoing and the cyclicality and volatility of the industries we serve, it is difficult to predict future orders with precision and we may incur unexpected or additional costs to align our business op … than anticipated, which could reduce our gross profit, restrict our ability to fund our operations, and result in unanticipated reductions or delays in sales. If we do not obtain orders as we anticipate, we could have excess components for a specific product or finished goods inventory that we would not be able to sell to another customer, likel
Antoxerene Closes $10 Million Deal with Juvenescence to Develop Small Molecule Drugs for Diseases of Aging Skip to content Services Protein Services Protein Expression & Purification Services Adeno-Associated Virus (AAV) Structural Biology Services X-Ray Crystallography Services Biophysical Assays Surface Plasmon Resonance Services Biacore Assay Services Circular Dichroism (CD) Assay Services nanoDSF Assay Services Bio-layer Interferometry Services Isothermal Titration Calorimetry Plate-Based Assay Services View All Protein Services Pharmacology Services Drug Discovery Services Drug Devel
Tietosuojavalintasi guce guce Tietosuojasi on meille tärkeää Tietosuojavalintojasi käytetään kaikissa Yahoo-konsernin tarjoamissa sivustoissa ja sovelluksissa. Yahoo käyttää evästekäytännöstämme ."> Evästeet Evästeiden (sekä vastaavien tekniikoiden, esimerkiksi verkkotallennuksen) avulla verkkosivustojen sovellusten ylläpitäjät voivat tallentaa ja lukea laitteesi tietoja. Lue lisää evästekäytännöstämme . evästeitä seuraaviin tarkoituksiin: tarjotaksemme sivustomme ja sovelluksemme sinulle todentaaksemme käyttäjät, estääksemme roskapostia ja väärinkäytöksiä sekä toteuttaaksemme tietoturvatoimia
ICHOR HOLDINGS, LTD. SEC 10-K Report — TradingView News Search Products Community Markets Brokers More EN Get started News / TradingView / ICHOR HOLDINGS, LTD. SEC 10-K Report ICHOR HOLDINGS, LTD. SEC 10-K Report 5 min read ICHR Ichor Holdings, Ltd., a leading provider of critical fluid delivery subsystems and components for the semiconductor capital equipment industry, has released its 2025 Form 10-K report. The report details the company's financial performance, business operations, strategic initiatives, and the challenges it faces in the current market environment. Financial Highlight … erial costs and demand. The company expects to maintain sufficient liquidity to fund its business and obligations for at least the next 12 months and beyond, leveraging cash flows from operations and available credit facilities. Challenges and Risks Economic and Strategic Risks: The company faces significant economic and strategic risks due to its dependence on the semiconductor capital equipment industry, which is subject to cyclical downturns and volatility. This dependency
Ichor Medical Systems, sponsor of | Manufacturing 2016 Toggle navigation World Vaccine Manufacturing Congress Washington 29 - 31 March 2016 Grand Hyatt, Washington D.C., USA home our story The big idea invitation from Dr. Poland testimonials VIE awards VIE awards - Nominees sponsor / exhibit why sponsor/exhibit? who should sponsor / exhibit? floor plan sponsors & exhibitors partners 2015 event report download sponsorship brochure agenda why attend? who attends? agenda at a glance speakers cancer & immunotherapy influenza & respiratory emerging & re-emerging diseases clinical tr … tact us Ichor Medical Systems Bronze Sponsor Ichor is dedicated to the clinical application and commercialization of its TriGrid™ electroporation technology for the delivery of nucleic acid based biologics to treat a broad spectrum of disease indications including cancer, chronic viral infections, HIV, ebola and multiple biodefense agents. Ichor has established several ongoing research and development collaborations and licensing agreements to advance the development of its T
- YouTube Info Presse Urheberrecht Kontakt Creator Werben Entwickler Impressum Verträge hier kündigen Nutzungsbedingungen Datenschutz Richtlinien & Sicherheit Wie funktioniert YouTube? Neue Funktionen testen © 2026 Google LLC
Ichor posts Q1 2026 loss on higher sales | ICHR Quarterly Report (10-Q) --> STOCK TITAN Login Sign up Login Sign up 0 HOME --> NEWS FEED Stock News Live Stock News Today Trending News AI news FDA Approvals Clinical Trials Crypto News Merger & Acquisitions Earnings Offerings IPO News Stock Splits Top News - Gainers Top News - Losers SEC FILINGS SEC Filings Live SEC Filings Today Form 4 - Insider Trading 8-K - Material Events 10-K - Annual Reports 10-Q - Quarterly Reports DEF 14A - Proxy Statements S-1 - IPO Registration S-3 - Shelf Registration STOCKS All Stock Themes AI Stocks Crypto Stocks Oi … Holdings (NASDAQ: ORBS) Reports Total Holdings of Approxi... DLHC DLH Contract Award Opens New Growth Channels with U.S Navy RKLB NASA Selects Rocket Lab to Launch Sun, Earth Sciences Missions SHPH United Dogecoin Advances Data Centre and Power Infrastructure Str... ON onsemi to Acquire Synaptics to Enable the Next Generation of Inte... ILLR Triller Group (Nasdaq: ILLR): The Reverse Split Is Not the Story ... BMNR ORBS Eightco Holdings (NASDAQ: ORBS) Reports Total Holdings o … Holdings (NASDAQ: ORBS) Reports Total Holdings of Approxi... DLHC DLH Contract Award Opens New Growth Channels with U.S Navy Previous Next --> Overview Financials News SEC Filings Higher Q1 2026 sales but net loss for Ichor (NASDAQ: ICHR) Filing Impact (Moderate) Filing Sentiment (Neutral) Form Type 10-Q Rhea-AI Filing Summary English Italian Spanish German Korean French Arabic Ichor Holdings reported first‑quarter 2026 net sales of $256.1 million , up from $244.5 … eding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes   x     No   o Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non‑accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,& … s generally vest over four years , 25 % on the first anniversary of the date of grant and quarterly thereafter over the remaining three years . Upon vesting of RSUs, shares are withheld to cover statutory minimum withholding taxes. Shares withheld are not reflected as an issuance of ordinary shares within our consolidated statements of shareholde
Ichor Medical Systems, Inc. H-1B & PERM Sponsorship Data | Visa Bulletin U.S. Immigration Data Priority dates, work visas, and labor market data Visa Bulletin Salaries Roles Employers FAQ About Contact Support Ichor Medical Systems, Inc. H-1B & Green Card Sponsorship Data Source: US Dept of Labor. Represents Base Salary only. Excludes RSUs, signing bonuses, and variable compensation. View All Salary Records Search for another employer Years of Data Last 3 Years Last 5 Years Last 10 Years All Available Years Visa Program All Programs H-1B Only Green Card Only 1 Total Filings 2021-Presen
ITI Enters into License Agreement with Ichor to Use Electroporation (EP) Delivery Technology in Phase I Study of DNA Vaccine Therapy, ITI-1001 - Immunomic Therapeutics Search for: Pipeline Partnerships Clinical Trials ITI-1000: Glioblastoma Multiforme ITI-1001: Glioblastoma Multiforme ITI-3000: Merkel Cell Carcinoma Team Careers Media Contact Us Pipeline Partnerships Clinical Trials ITI-1000: Glioblastoma Multiforme ITI-1001: Glioblastoma Multiforme ITI-3000: Merkel Cell Carcinoma Team Careers Media Contact Us ITI Enters into License Agreement with Ichor to Use Electroporation (EP) Delivery Te … al immune responses in clinical trials. Ichor’s TriGrid technology utilizes the application of electrical fields in a target tissue to increase intracellular nucleic acid uptake in the local area, resulting in enhanced gene expression. “We are excited to partner with Ichor on our ITI-1001 program. Their TriGrid® technology is a great match for our nucleic acid approach. By combining our technologies, we aim to enhance immune responses to the viral antigens of Cytomegalovirus … Company’s questions and provided feedback on key components of the planned IND application for the candidate, ITI-1001, for the treatment of newly diagnosed Glioblastoma Multiforme (GBM). In the planned First-In-Human Phase I trial, ITI will evaluate the safety, tolerability, immunogenicity and preliminary efficacy of ITI-1001 in patients with newly-diagnosed GBM having unmethylated MGMT promoter mutations. The Phase I trial is anticipated to start in 2021. “DNA vaccines are
ICHOR HOLDINGS, LTD. (Form: 10-K, Received: 02/21/2025 09:00:25) 000165253500-00000002024FYFALSELarge Accelerated FilerP1Yxbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:pureichr:Segment00016525352023-12-302024-12-2700016525352025-02-1800016525352024-06-2800016525352024-09-282024-12-2700016525352024-12-2700016525352023-12-2900016525352022-12-312023-12-2900016525352022-01-012022-12-300001652535us-gaap:CommonStockMember2021-12-310001652535us-gaap:AdditionalPaidInCapitalMember2021-12-310001652535us-gaap:TreasuryStockCommonMember2021-12-310001652535us-gaap:RetainedEarningsMember2021-12-3100016 … eding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non‑accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in … o the chemical delivery subsystem, we also manufacture the process modules that apply the various chemicals directly to the wafer in a process-and application-unique manner to create the desired chemical reaction. 5 Table of Contents The image below shows a typical wet-process front end semiconductor tool, with a chemical delivery subsystem and corresponding application process module highlighted: Weldments and Specialty Joining Our complete offering of weldments support the … ommit to minimum purchase volumes. While most of our customers provide periodic rolling forecasts for product orders, those forecasts do not become binding until a formal purchase order is submitted, which generally occurs only a short time prior to shipment. As a result of the foregoing and the cyclicality and volatility of the industries we serve, it is difficult to predict future orders with precision and we may incur unexpected or additional costs to align our business op … than anticipated, which could reduce our gross profit, restrict our ability to fund our operations, and result in unanticipated reductions or delays in sales. If we do not obtain orders as we anticipate, we could have excess components for a specific product or finished goods inventory that we would not be able to sell to another customer, likel
ICHOR SYSTEMS INC H-1B Visa Sponsorship Data FY2025 | GradJobs | grad.jobs Skip to main content H-1B Sponsors ICHOR SYSTEMS INC ICHOR SYSTEMS INC Grade: B Data: FY2025 View Company Profile View Jobs LCA Filings 0 0 certified Approval Rate 100.0% 2 approvals / 0 denials Avg Salary - Median: - Green Card (PERM) 0 0 certified Yearly Trends Fiscal Year LCA Total Certified Approval Rate Avg Salary FY2025 0 0 100.0% - Understanding the Grade Our sponsorship grade is calculated based on approval rate, petition volume, salary vs prevailing wage, green card sponsorship, and compliance history. A+ / A E … r sponsor grad.jobs AI-first career copilot Build standout resumes, track every application, and let AI keep you interview-ready. Designed for ambitious grads shipping their best career story. 10k+ job seekers supported 4.9/5 avg. satisfaction 300k+ jobs indexed Trustpilot Product Overview Resume Hub Job Tracker Outreach AI Tools Explore Companies H-1B Sponsors Green Card Sponsors OPT Employers Best Companies Salary Benchmarks Resources Blog FAQ Support Center Changelog Compa
Please ensure Javascript is enabled for purposes of website accessibility Skip to main content
Orthotopic Mouse Models | Ichor Life Sciences Skip to content Services Protein Services Protein Expression & Purification Services Adeno-Associated Virus (AAV) Structural Biology Services X-Ray Crystallography Services Biophysical Assays Surface Plasmon Resonance Services Biacore Assay Services Circular Dichroism (CD) Assay Services nanoDSF Assay Services Bio-layer Interferometry Services Isothermal Titration Calorimetry Plate-Based Assay Services View All Protein Services Pharmacology Services Drug Discovery Services Drug Development Services Lead Discovery Services Lead Optimization Ser
4T1 Mouse Model | Ichor Life Sciences Skip to content Services Protein Services Protein Expression & Purification Services Adeno-Associated Virus (AAV) Structural Biology Services X-Ray Crystallography Services Biophysical Assays Surface Plasmon Resonance Services Biacore Assay Services Circular Dichroism (CD) Assay Services nanoDSF Assay Services Bio-layer Interferometry Services Isothermal Titration Calorimetry Plate-Based Assay Services View All Protein Services Pharmacology Services Drug Discovery Services Drug Development Services Lead Discovery Services Lead Optimization Services Hi
Ichor Systems - Contact information for H1B visa and greencard sponsorship applications "> Welcome, Guest Login Register for Free! Immihelp Welcome, Guest Login Register for Free! Home Greencard Visas Insurance Experiences Forum Tracker USA Travel NRI Tools Blog Select Language For visitors, travel, student and other international travel medical insurance. Visit insubuy.com or call +1 (866) INSUBUY or +1 (972) 985-4400 Home » ICHOR SYSTEMS » Contacts Print Share Facebook X LinkedIn WhatsApp Email Share on Facebook X LinkedIn WhatsApp Email Employer Explore more Home - H1B Sponsors Home - … hor Systems since 2008. Address 200 PARKER DR STE C600, AUSTIN, TX 78728-1231 1 Application 200C PARKER DR, AUSTIN, TX 78728-1228 2 Applications 9660 SW HERMAN RD, TUALATIN, OR 97062-7905 3 Applications 3185 LAURELVIEW CT, FREMONT, CA 94538-6535 14 Applications Phone Number 512 5998795 (512) 246-5547 512 2465104 (510) 897-5200 (503) 783-2006 503 7832006 Email Address dfinucane#*#ichorsystems.com aybarra#*#ichorsystems.com JSPEER#*#ICHORSYSTEMS.COM Disclaimer: The H1B Sponsors
Ichor | Loretto Skip to content Ichor Partnership Loretto is partnering with Ichor Research to offer Alzheimer’s disease and dementia clinical trial opportunities for Loretto residents. This unique partnership between a research organization and a senior healthcare provider will make investigational diagnostic and medicinal interventions available to Loretto residents, family members and employees. This partnership offers Loretto residents, families, and employees access to clinical trials that provide interventions and medications that may help those living with Alzheimer’s and related dement … mpensation for participation. Each trial is different, and if they do provide a stipend that amount is typically fixed and pre-approved by an ethics board. How to Qualify for a Clinical Trial Every study has unique criteria for determining who can participate. Your medical history, medications, and current health status are considered when evaluating different study options. Only those who are medically suitable for a clinical trial will be offered the opportunity to enroll.
ichr-20251226 0001652535 00-0000000 2025 FY FALSE P7Y P1Y 1 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure ichr:segment ichr:lease 0001652535 2024-12-28 2025-12-26 0001652535 2026-02-13 0001652535 2025-06-27 0001652535 2025-09-27 2025-12-26 0001652535 2025-12-26 0001652535 2024-12-27 0001652535 2023-12-30 2024-12-27 0001652535 2022-12-31 2023-12-29 0001652535 us-gaap:CommonStockMember 2022-12-30 0001652535 us-gaap:AdditionalPaidInCapitalMember 2022-12-30 0001652535 us-gaap:TreasuryStockCommonMember 2022-12-30 0001652535 us-gaap:RetainedEarningsMember 2022-12-30 0001652535 2022-12 … eding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non‑accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in … the chemical delivery subsystems, we also manufacture the process modules that apply chemicals directly to the wafer in a process- and application-unique manner to create the desired chemical reaction. 5 Table of Contents The image below shows a typical wet-process front end semiconductor tool, with a chemical delivery subsystem and corresponding application process module highlighted: Weldments and Specialty Joining Our complete offering of weldments support the delivery of … ommit to minimum purchase volumes. While most of our customers provide periodic rolling forecasts for product orders, those forecasts do not become binding until a formal purchase order is submitted, which generally occurs only a short time prior to shipment. As a result of the foregoing and the cyclicality and volatility of the industries we serve, it is difficult to predict future orders with precision and we may incur unexpected or additional costs to align our business op … than anticipated, which could reduce our gross profit, restrict our ability to fund our operations, and result in unanticipated reductions or delays in sales. If we do not obtain orders as we anticipate, we could have excess components for a specific product or finished goods inventory that we would not be able to sell to another customer, likel
PDAC Mouse Model | Ichor Life Sciences Skip to content Services Protein Services Protein Expression & Purification Services Adeno-Associated Virus (AAV) Structural Biology Services X-Ray Crystallography Services Biophysical Assays Surface Plasmon Resonance Services Biacore Assay Services Circular Dichroism (CD) Assay Services nanoDSF Assay Services Bio-layer Interferometry Services Isothermal Titration Calorimetry Plate-Based Assay Services View All Protein Services Pharmacology Services Drug Discovery Services Drug Development Services Lead Discovery Services Lead Optimization Services H
Ichor Medical Systems, sponsor of | Vaccine Trials 2016 Toggle navigation World Vaccine Trials Conference 2016 29 - 30 March Grand Hyatt, Washington D.C., USA home our story The big idea invitation from Dr. Poland testimonials VIE awards VIE awards - Nominees sponsor /exhibit why sponsor? who sponsors/exhibits? floor plan sponsors & exhibitors 2015 event report partners sponsor / exhibit now download sponsorship brochure agenda agenda at a glance why attend? who attends? speakers cancer & immunotherapy influenza & respiratory emerging & re-emerging diseases clinical trials biop … tact us Ichor Medical Systems Bronze Sponsor Ichor is dedicated to the clinical application and commercialization of its TriGrid™ electroporation technology for the delivery of nucleic acid based biologics to treat a broad spectrum of disease indications including cancer, chronic viral infections, HIV, ebola and multiple biodefense agents. Ichor has established several ongoing research and development collaborations and licensing agreements to advance the development of its T
Xenograft Mouse Models | Ichor Life Sciences Skip to content Services Protein Services Protein Expression & Purification Services Adeno-Associated Virus (AAV) Structural Biology Services X-Ray Crystallography Services Biophysical Assays Surface Plasmon Resonance Services Biacore Assay Services Circular Dichroism (CD) Assay Services nanoDSF Assay Services Bio-layer Interferometry Services Isothermal Titration Calorimetry Plate-Based Assay Services View All Protein Services Pharmacology Services Drug Discovery Services Drug Development Services Lead Discovery Services Lead Optimization Serv
Flow Cytometry Services | Ichor Life Sciences Skip to content Services Protein Services Protein Expression & Purification Services Adeno-Associated Virus (AAV) Structural Biology Services X-Ray Crystallography Services Biophysical Assays Surface Plasmon Resonance Services Biacore Assay Services Circular Dichroism (CD) Assay Services nanoDSF Assay Services Bio-layer Interferometry Services Isothermal Titration Calorimetry Plate-Based Assay Services View All Protein Services Pharmacology Services Drug Discovery Services Drug Development Services Lead Discovery Services Lead Optimization Ser … ell divisions post-injection from samples. Instruments for Every Flow Cytometry Application No single flow cytometer can accommodate every project need. That's why we use a collection of instruments to provide full flow cytometry services. Our small 2-laser BD Accuri C6, provides fast analysis for simple 2-4 marker experiments such as basic cell engraftment, cell transductions efficiency and apoptosis assays. Our 3-laser BD LSR Fortessa Cell Analyzer provides streamlined samp … ntiated cells, and incorporating additional labels to probe cell function. This application is especially relevant to hematopoietic lineages, where immune cell function can determine disease outcomes. Regulatory T-cells (T-regs) are a subset of immune cells implicated in immune response regulation and self-tolerance. T-regs can be identified among a mixed cell population by their expression of the transcription factor FOXP3. Here, a complex sample of primary murine leukocytes
Publications | Ichor Life Sciences Skip to content Services Protein Services Protein Expression & Purification Services Adeno-Associated Virus (AAV) Structural Biology Services X-Ray Crystallography Services Biophysical Assays Surface Plasmon Resonance Services Biacore Assay Services Circular Dichroism (CD) Assay Services nanoDSF Assay Services Bio-layer Interferometry Services Isothermal Titration Calorimetry Plate-Based Assay Services View All Protein Services Pharmacology Services Drug Discovery Services Drug Development Services Lead Discovery Services Lead Optimization Services High
Ichor program investment and partnerships | Ichor Life Sciences Skip to content Services Protein Services Protein Expression & Purification Services Adeno-Associated Virus (AAV) Structural Biology Services X-Ray Crystallography Services Biophysical Assays Surface Plasmon Resonance Services Biacore Assay Services Circular Dichroism (CD) Assay Services nanoDSF Assay Services Bio-layer Interferometry Services Isothermal Titration Calorimetry Plate-Based Assay Services View All Protein Services Pharmacology Services Drug Discovery Services Drug Development Services Lead Discovery Services Lea
Hit-to-Lead Discovery Services | Ichor Life Sciences Skip to content Services Protein Services Protein Expression & Purification Services Adeno-Associated Virus (AAV) Structural Biology Services X-Ray Crystallography Services Biophysical Assays Surface Plasmon Resonance Services Biacore Assay Services Circular Dichroism (CD) Assay Services nanoDSF Assay Services Bio-layer Interferometry Services Isothermal Titration Calorimetry Plate-Based Assay Services View All Protein Services Pharmacology Services Drug Discovery Services Drug Development Services Lead Discovery Services Lead Optimizat
Clinical Trial Close Out Services | Ichor Life Sciences Skip to content Services Protein Services Protein Expression & Purification Services Adeno-Associated Virus (AAV) Structural Biology Services X-Ray Crystallography Services Biophysical Assays Surface Plasmon Resonance Services Biacore Assay Services Circular Dichroism (CD) Assay Services nanoDSF Assay Services Bio-layer Interferometry Services Isothermal Titration Calorimetry Plate-Based Assay Services View All Protein Services Pharmacology Services Drug Discovery Services Drug Development Services Lead Discovery Services Lead Optimi
Ichor lands $1.35 million, attracts international investors Skip to content Services Protein Services Protein Expression & Purification Services Adeno-Associated Virus (AAV) Structural Biology Services X-Ray Crystallography Services Biophysical Assays Surface Plasmon Resonance Services Biacore Assay Services Circular Dichroism (CD) Assay Services nanoDSF Assay Services Bio-layer Interferometry Services Isothermal Titration Calorimetry Plate-Based Assay Services View All Protein Services Pharmacology Services Drug Discovery Services Drug Development Services Lead Discovery Services Lead Op … mmunePath, Inc., a start-up biotech company backed by Peter Thiel and Founder’s Fund . In 2012, he returned to the Syracuse area to attend SUNY Upstate Medical University. As a medical student, Moody independently won a $540,000 research grant from Life Extension Foundation , which he used to found Ichor Therapeutics. https://web.archive.org/web/2017083008570“It was actually easier and less expensive for me to create a start-up company in my apartment than to operate through
Careers | Ichor Life Sciences Skip to content Services Protein Services Protein Expression & Purification Services Adeno-Associated Virus (AAV) Structural Biology Services X-Ray Crystallography Services Biophysical Assays Surface Plasmon Resonance Services Biacore Assay Services Circular Dichroism (CD) Assay Services nanoDSF Assay Services Bio-layer Interferometry Services Isothermal Titration Calorimetry Plate-Based Assay Services View All Protein Services Pharmacology Services Drug Discovery Services Drug Development Services Lead Discovery Services Lead Optimization Services High Conte
Careers | Ichor Life Sciences Skip to content Services Protein Services Protein Expression & Purification Services Adeno-Associated Virus (AAV) Structural Biology Services X-Ray Crystallography Services Biophysical Assays Surface Plasmon Resonance Services Biacore Assay Services Circular Dichroism (CD) Assay Services nanoDSF Assay Services Bio-layer Interferometry Services Isothermal Titration Calorimetry Plate-Based Assay Services View All Protein Services Pharmacology Services Drug Discovery Services Drug Development Services Lead Discovery Services Lead Optimization Services High Conte
Ichor Life Sciences Announces Launch of Ichor Clinical Trial Services - Ichor Life Sciences Skip to content Services Protein Services Protein Expression & Purification Services Adeno-Associated Virus (AAV) Structural Biology Services X-Ray Crystallography Services Biophysical Assays Surface Plasmon Resonance Services Biacore Assay Services Circular Dichroism (CD) Assay Services nanoDSF Assay Services Bio-layer Interferometry Services Isothermal Titration Calorimetry Plate-Based Assay Services View All Protein Services Pharmacology Services Drug Discovery Services Drug Development Services
Genetic Modulation Services | Ichor Life Sciences Skip to content Services Protein Services Protein Expression & Purification Services Adeno-Associated Virus (AAV) Structural Biology Services X-Ray Crystallography Services Biophysical Assays Surface Plasmon Resonance Services Biacore Assay Services Circular Dichroism (CD) Assay Services nanoDSF Assay Services Bio-layer Interferometry Services Isothermal Titration Calorimetry Plate-Based Assay Services View All Protein Services Pharmacology Services Drug Discovery Services Drug Development Services Lead Discovery Services Lead Optimization … rstand your project needs and design optimized gene sequences tailored for your application, ensuring high expression efficiency, compatibility with your chosen delivery system, and relevance to downstream functional readouts. DNA/RNA Extraction We regularly extract nucleic acids from tissue, blood, and cell samples, as well as specialized materials such as patient bandages, with comprehensive quantity, quality, and purity assessments for downstream analyses. Differential Gen
PK/PD Services | Ichor Life Sciences Skip to content Services Protein Services Protein Expression & Purification Services Adeno-Associated Virus (AAV) Structural Biology Services X-Ray Crystallography Services Biophysical Assays Surface Plasmon Resonance Services Biacore Assay Services Circular Dichroism (CD) Assay Services nanoDSF Assay Services Bio-layer Interferometry Services Isothermal Titration Calorimetry Plate-Based Assay Services View All Protein Services Pharmacology Services Drug Discovery Services Drug Development Services Lead Discovery Services Lead Optimization Services Hig
Biochemical Assay Development | Ichor Life Sciences Skip to content Services Protein Services Protein Expression & Purification Services Adeno-Associated Virus (AAV) Structural Biology Services X-Ray Crystallography Services Biophysical Assays Surface Plasmon Resonance Services Biacore Assay Services Circular Dichroism (CD) Assay Services nanoDSF Assay Services Bio-layer Interferometry Services Isothermal Titration Calorimetry Plate-Based Assay Services View All Protein Services Pharmacology Services Drug Discovery Services Drug Development Services Lead Discovery Services Lead Optimizati
Clarkson University and Ichor Life Sciences Partner to Establish Biotechnology Cluster in North Country - Ichor Life Sciences Skip to content Services Protein Services Protein Expression & Purification Services Adeno-Associated Virus (AAV) Structural Biology Services X-Ray Crystallography Services Biophysical Assays Surface Plasmon Resonance Services Biacore Assay Services Circular Dichroism (CD) Assay Services nanoDSF Assay Services Bio-layer Interferometry Services Isothermal Titration Calorimetry Plate-Based Assay Services View All Protein Services Pharmacology Services Drug Discovery
Cell-Based Assays | Ichor Life Sciences Skip to content Services Protein Services Protein Expression & Purification Services Adeno-Associated Virus (AAV) Structural Biology Services X-Ray Crystallography Services Biophysical Assays Surface Plasmon Resonance Services Biacore Assay Services Circular Dichroism (CD) Assay Services nanoDSF Assay Services Bio-layer Interferometry Services Isothermal Titration Calorimetry Plate-Based Assay Services View All Protein Services Pharmacology Services Drug Discovery Services Drug Development Services Lead Discovery Services Lead Optimization Services
Ichor CEO delivers workshop and Lysoclear update at annual LEAF conference - Ichor Life Sciences Skip to content Services Protein Services Protein Expression & Purification Services Adeno-Associated Virus (AAV) Structural Biology Services X-Ray Crystallography Services Biophysical Assays Surface Plasmon Resonance Services Biacore Assay Services Circular Dichroism (CD) Assay Services nanoDSF Assay Services Bio-layer Interferometry Services Isothermal Titration Calorimetry Plate-Based Assay Services View All Protein Services Pharmacology Services Drug Discovery Services Drug Development Ser
Kelsey Moody - College of Arts & Sciences at Syracuse University Kelsey Moody Orange Alert Search Search Give Online --> Give Online Menu ☰ Home Admissions Academics Student Success Alumni Research More Academics Departments Majors & Minors Renee Crown Honors Program People Faculty listing Part Time Faculty listing Emeritus Faculty Staff listing Named Chairs & Professorships In Memoriam Administrative Units Student Success Liberal Arts Core Degree Completion PreLaw PreHealth Registration Admissions Undergraduate Graduate News & Events News Events Office of Communications Home Co … e Dean Academic Strategic Plan Internal Forms History Research Student Centered Proposal Development Clusters & Groups Information for... Faculty and Staff Prospective Students Current Students Employers Quick Links syracuse.edu You are here: Arts & Sciences People Affiliated Kelsey Moody Kelsey Moody AFFILIATIONS Physics Affiliated Faculty, CEO and Founder of ICHOR CONTACT Email: [email protected] Entries in the areas listed below (other than biography a
Kelsey Moody on leadership: Be coachable and hire people who can teach you Skip to content Services Protein Services Protein Expression & Purification Services Adeno-Associated Virus (AAV) Structural Biology Services X-Ray Crystallography Services Biophysical Assays Surface Plasmon Resonance Services Biacore Assay Services Circular Dichroism (CD) Assay Services nanoDSF Assay Services Bio-layer Interferometry Services Isothermal Titration Calorimetry Plate-Based Assay Services View All Protein Services Pharmacology Services Drug Discovery Services Drug Development Services Lead Discovery S … edical student at Upstate Medical University when he landed a $540,000 research grant and set up his own pharmaceutical research company. “After we had cleared our first million dollars in funding for the company, I had to choose: Did I want to finish my medical doctorate or did I want to gamble on the company? I chose the company, and it’s continued to take off since then. I think I made the right choice.” He pauses, points to a wall of photos, and laughs: “Every year, we ki
Our Team | Ichor Life Sciences Skip to content Services Protein Services Protein Expression & Purification Services Adeno-Associated Virus (AAV) Structural Biology Services X-Ray Crystallography Services Biophysical Assays Surface Plasmon Resonance Services Biacore Assay Services Circular Dichroism (CD) Assay Services nanoDSF Assay Services Bio-layer Interferometry Services Isothermal Titration Calorimetry Plate-Based Assay Services View All Protein Services Pharmacology Services Drug Discovery Services Drug Development Services Lead Discovery Services Lead Optimization Services High Cont … cule, antibody mimetics, contract research services, and a strategic investment fund. Dr. Moody holds a PhD from University of Miami's Miller School of Medicine in Biochemistry and Molecular Biology, and an MBA from Concordia University Wisconsin. LinkedIn Kelsey Moody, PhD, MBA Chief Executive Officer Read Bio Aaron Wolfe, PhD Chief Science Officer Dr. Wolfe holds a PhD in Structural Biology, Biochemistry, and Biophysics (SB3) from Syracuse University. During his graduate wo … the helm of the clinic, Lisa was awarded the Health Care Innovator of the Year award in 2019 by the Central New York Business Journal for her work in establishing no-cost memory screening and preventative baseline cognitive testing for her community. In 2021, Clarity was acquired by the world’s largest research site network. With a deep understanding of the operations of research sites, Lisa brings a unique perspective to Ichor Clinical with a focus on real-world preventativ
Internships | Ichor Life Sciences Skip to content Services Protein Services Protein Expression & Purification Services Adeno-Associated Virus (AAV) Structural Biology Services X-Ray Crystallography Services Biophysical Assays Surface Plasmon Resonance Services Biacore Assay Services Circular Dichroism (CD) Assay Services nanoDSF Assay Services Bio-layer Interferometry Services Isothermal Titration Calorimetry Plate-Based Assay Services View All Protein Services Pharmacology Services Drug Discovery Services Drug Development Services Lead Discovery Services Lead Optimization Services High C … stors, employers, and professionals. Get Paid Repeat interns are eligible for a stipend. Who is an ideal candidate? Our internship program combines the scientific rigor of a traditional internship with industrial speed and scope. By design, ours is an intense immersion experience designed to challenge while providing exposure to a wide range of marketable skills. Successful students in the program have landed job offers with Ichor and our partners, led their own projects, and … e continued on as a paid consultant to the company! Amanda Self, 22’ Internship Application Frequently Asked Questions What are the date(s) associated with each internship period? Exact dates are determined with each student on a case-by-case basis, but typically follow an academic year: Fall semester: August 20th – December 20th Winter break: December 20th – January 15th Spring semester: January 15th – May 15th Summer break: May 26th – August 20 th How many hours per week wi … 25 hrs/week strongly encouraged; more hours available upon request What is the deadline for the application? Summer - March 1st Fall - June 1st Winter - September 1st Spring - October 1st I am a high school student. What will make my application most competitive? We frequently accept high school applicants to our internship program, with a preference for students local to LaFayette or the greater Syracuse area. Competitive applicants will typically have >90% high school G … fit” and get a foot in the door with the team. All applicants are encouraged to submit materials for an informal review and to identify gaps in the application before applying for an internship. For inquiries about shadowing experiences or to have an informal review of application materials, please contact us. The dos: Do reach out to us early fo
Climbing to success - Lisa Sonneborn - Ichor Life Sciences | Ep71 - The Huxley Morton Podcast | Podcast on Spotify
Episode 16 - Dr. Kelsey Moody - A4LI H-SPAN Podcast - Apple 播客 搜索 主页 新发现 排行榜 搜索 2024年2月29日 37 分钟 Episode 16 - Dr. Kelsey Moody A4LI H-SPAN Podcast 播放 This week on H-SPAN, we sat down with Kelsey Moody, CEO at Ichor Life Sciences, Inc. In this episode, we discuss how Kelsey started Ichor, what the future holds in terms of growth and expansion, as well as Ichor’s activities in the longevity investment space. 单集网页 信息 节目 A4LI H-SPAN Podcast 频率 一月一更 发布时间 2024年2月29日 UTC 19:11 时长 37 分钟 单集 16 分级 儿童适宜 美国 (简体中文) Español (México) العربية Русский Français (France) 한국어 Português (Brazil) Tiếng Việt 繁
Blog | Inviting Innovation: Importance of Translational Cancer Research Skip to content Search for: twitter facebook instagram spotify social_icon_custom_1 social_icon_custom_2 social_icon_custom_3 The Game On Glio Podcast Home Resources Local Resources Blog Grace. Guidance. Gratitude Contact Us Donate Home » Inviting Innovation: The Impact of Translational Cancer Research December 8, 2025 / Grace. Guidance. Gratitude Inviting Innovation: The Impact of Translational Cancer Research Thanks to decades of work into prevention, diagnosis, and treatment, 1 in 2 people diagnosed with cancer to
Kelsey Moody - Ichor Life Sciences - Interviews - LONGECITY ....................... Google Sign in options Remember me This is not recommended for shared computers Sign in anonymously Don't add me to the active users list Privacy Policy Sign In Create Account ::: --> L onge C ity Advocacy & Research for Unlimited Lifespans .org About UserAgreement Constitution Stewards MembersList Districts Homepage Portal Forum Blogs FacebookPage Media Newsletter Podcast
Episode 16 - Dr. Kelsey Moody–A4LI H-SPAN Podcast – Apple Podcasts Search Home New Top Charts Search 29 February 2024 37 min Episode 16 - Dr. Kelsey Moody A4LI H-SPAN Podcast Play This week on H-SPAN, we sat down with Kelsey Moody, CEO at Ichor Life Sciences, Inc. In this episode, we discuss how Kelsey started Ichor, what the future holds in terms of growth and expansion, as well as Ichor’s activities in the longevity investment space. Episode Webpage Information Show A4LI H-SPAN Podcast Frequency Monthly Published 29 February 2024 at 19:11 UTC Length 37 min Episode 16 Rating Clean Norwa
Episode 16 - Dr. Kelsey Moody | Ichor Life Sciences, Inc. LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement , Privacy Pol
Facebook Explore the things you love . Log into Facebook Email or mobile number Password Log in Forgot password? Create new account English (US) فارسی العربية Türkçe Deutsch Français (France) Polski More languages… Sign Up Log In Messenger Facebook Lite Video Meta Pay Meta Store Meta Quest Ray-Ban Meta Meta AI Instagram Threads Privacy Policy Privacy Center About Create ad Create Page Developers Careers Cookies Ad choices Terms Help Contact Uploading & Non-Users Meta © 2026
%PDF-1.7 %���� 1656 0 obj > endobj 1669 0 obj >/Filter/FlateDecode/ID[ ]/Index[1656 27]/Info 1655 0 R/Length 72/Prev 131223/Root 1657 0 R/Size 1683/Type/XRef/W[1 2 1]>>stream h�bbd``b`: $W�X�@�q ��H0k�� n"�e"�@�H� H�Kf`bdc�� ���� `� endstream endobj startxref 0 %%EOF 1682 0 obj >stream h�b```�~6Vʰ!�o�\����V�����sd`�Z���60@�2 d`�� ����$�� d�"�c3c�n�>��9�K�dڛ�u10ξR��X��q�~�I ���.Tc`���@�5s&O endstream endobj 1657 0 obj >/Metadata 36 0 R/Outlines 40 0 R/Pages 1654 0 R/StructTreeRoot 42 0 R/Type/Catalog/ViewerPreferences 1670 0 R>> endobj 1658 0 obj >/Med … )�-��CE�w~ �֭�m�,�� ��I��u�,Q�@mr�o�K�-d�� endstream endobj 36 0 obj >stream application/pdf Hannah Microsoft Word 2022-03-30T16:03:55-07:00 2022-03-30T19:04:38-04:00 2022-03-30T19:04:38-04:00 uuid:AAECD862-826F-43EA-A26C-1093B438A6CC uuid:1183de87-840e-4b1f-97d8-da1357b01463 endstream endobj 37 0 obj >stream h�2435Q0P���w�/�+Q����L)�643� )�Ic0i &���%D"m�7+���,H�HLO-��0� endstream endobj 38 0 obj >stream h�\˻ � �Wq���K�!D-��҅Z�����hj?'+�b`m˻+����:g���~�� gl
ichor_developer, Author at Ichor Life Sciences - Page 2 of 3 Skip to content Services Protein Services Protein Expression & Purification Services Adeno-Associated Virus (AAV) Structural Biology Services X-Ray Crystallography Services Biophysical Assays Surface Plasmon Resonance Services Biacore Assay Services Circular Dichroism (CD) Assay Services nanoDSF Assay Services Bio-layer Interferometry Services Isothermal Titration Calorimetry Plate-Based Assay Services View All Protein Services Pharmacology Services Drug Discovery Services Drug Development Services Lead Discovery Services Lead O
VIVA Exhibitors | VIVA - --> Conference Agendas (current) Events Calendar (current) News (current) Claim CME (current) 2025 2024 Content Library (current) Featured Videos Sponsored Sessions Virtual Sessions On Demand The VIVA Foundation About Us Board of Directors Founders Awards Donate VIVA Conference Program Overview Agenda Faculty Accreditation Late-Breaking Clinical Trials Innovation Summit: Red Horizons Physicians in Training Early Career Physicians World Insights Vascular Care Team Symposium Exhibit & Market Purchase Conference Content The VEINS Conference Program Overview Agenda Fac
ARVO 2026 Annual Meeting | Exhibitor Floor Plan Selected Exhibitor Search Results Available Booth Zoom In Zoom Out Max Fit Highlight Available Booths Display Booth Dimensions Orientation: Landscape Portrait Print Screenshot Include Booth Results: None Search Results Include Exhibitor Names on Floor Plan: Yes Print Hall(s): Current Hall All Halls Show Available Booths Your floor plan printout is processing. If you selected multiple halls it may take a minute for your print to finish. Loading... Creating Printout..... PRINT MY FLOOR PLAN
Ichor Inc. - Kitchener - Ontario - Canada - Jaclyn - Eventeny Skip to content or footer Organize Event Management Tools Event mapping Ticketing / registration Artist, vendor & exhibitor management Volunteer management Sponsor management Event programming & talent management - New Interactive schedules Hardware solutions Mobile app for organizers - New Solutions by event type About Eventeny Product overview Company values Pricing Helpful Resources Knowledge base Community center Comparison guide Blog Contact sales Product updates Case studies See all events Create an Event Participate Artis … keting text messages. Reply STOP to cancel, HELP for help. Msg & data rates may apply. Newsletter coming soon. In the meantime, browse new events. Subscribe Go to participant sign-up Browse events Eventeny was founded on the belief that managing large-scale events with hundreds of exhibitors, vendors, sponsors, and volunteers should not be stressful and burdensome. Our mission is to remove event organizers from being the 5th most stressful job in the world. That's why we buil
Ichor to Exhibit at Semicon Europa Industries Semiconductor Medical Aerospace General Industrial Expertise Engineering Manufacturing Design/Build Research Capabilities/Lab Refurbished Tools Capabilities Contract Manufacturing Custom Solutions Rapid Prototyping Custom Services Custom Stainless Steel Components Custom Tube Bending Services Orbital Welding Manual Welding Forming Electropolishing Exotic Materials Inconel® Machining Hastelloy® Maching Titanium Maching Copper Machining Nickel Machining Ceramic Machining Monel® Machining Plastics Equipment List Products Company About Corporate Social
JavaScript is disabled In order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.
Dr. William Gannon Joins the Ichor Science Advisory Board Skip to content Services Protein Services Protein Expression & Purification Services Adeno-Associated Virus (AAV) Structural Biology Services X-Ray Crystallography Services Biophysical Assays Surface Plasmon Resonance Services Biacore Assay Services Circular Dichroism (CD) Assay Services nanoDSF Assay Services Bio-layer Interferometry Services Isothermal Titration Calorimetry Plate-Based Assay Services View All Protein Services Pharmacology Services Drug Discovery Services Drug Development Services Lead Discovery Services Lead Opti
News | Ichor Life Sciences Skip to content Services Protein Services Protein Expression & Purification Services Adeno-Associated Virus (AAV) Structural Biology Services X-Ray Crystallography Services Biophysical Assays Surface Plasmon Resonance Services Biacore Assay Services Circular Dichroism (CD) Assay Services nanoDSF Assay Services Bio-layer Interferometry Services Isothermal Titration Calorimetry Plate-Based Assay Services View All Protein Services Pharmacology Services Drug Discovery Services Drug Development Services Lead Discovery Services Lead Optimization Services High Content
Ichor Announces Participation in 16th Annual CEO Investor Summit - Silicon UK AI Business Intelligence Cloud Digital transformation Data Marketing Security News BrandVoices Podcasts Whitepapers Webinars Events News BrandVoices Podcasts Whitepapers Webinars Events TECHNOLOGY POWERING BUSINESS Login Newsletter United Kingdom silicon.de silicon.fr silicon.pt silicon.es silicon.co.uk silicon.eu AI Business Intelligence Cloud Digital transformation Data Marketing Security All Tech News > Press Release Press release Ichor Announces Participation in 16th Annual CEO Investor Summit By businesswire
Lento Bio, Inc. Appoints Two Ichor Life Sciences Executives as a Member of the Board of Directors and Scientific Advisors - Ichor Life Sciences Skip to content Services Protein Services Protein Expression & Purification Services Adeno-Associated Virus (AAV) Structural Biology Services X-Ray Crystallography Services Biophysical Assays Surface Plasmon Resonance Services Biacore Assay Services Circular Dichroism (CD) Assay Services nanoDSF Assay Services Bio-layer Interferometry Services Isothermal Titration Calorimetry Plate-Based Assay Services View All Protein Services Pharmacology Servic
Ichor Life Sciences Expands Clinical Trial Services | Contract Pharma Continue to Contract Pharma Magazine Latest Issues Latest Issues Explore recent issues of Contract Pharma covering key industry trends. View all Digital Edition Digital Edition Read the full digital version of our magazine online. View all CEO Profiles CEO Profiles Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks. View all Subscribe Now Subscribe Now Stay informed
ichor_developer, Author at Ichor Life Sciences Skip to content Services Protein Services Protein Expression & Purification Services Adeno-Associated Virus (AAV) Structural Biology Services X-Ray Crystallography Services Biophysical Assays Surface Plasmon Resonance Services Biacore Assay Services Circular Dichroism (CD) Assay Services nanoDSF Assay Services Bio-layer Interferometry Services Isothermal Titration Calorimetry Plate-Based Assay Services View All Protein Services Pharmacology Services Drug Discovery Services Drug Development Services Lead Discovery Services Lead Optimization Se … cular lens. Upon successful completion of its first project, Lento Bio plans to apply its… Read More Ichor Life Sciences Portfolio Company, Auctus Biologics, Awarded NSF Grant to Develop New SPR Chip Technology LaFayette, N.Y. – Ichor Life Sciences, a premium pre-clinical contract research organization offering services in discovery through pharmacology, announces that portfolio company Auctus Biologics has been awarded a Phase I National Science Foundation Small Busin … warded a Phase I National Science Foundation Small Business Innovation Research grant (award # 2129469) for $228,697.00. The grant will fund development of a new optical biosensor chip technology for use in the biophysical technique of Surface Plasmon Resonance (SPR). The gold standard for studying biomolecular interactions in the pharmaceutical and biotechnology industries, SPR is an essential method for characterizing the interactions between small molecule drugs and their
Ichor Medical Systems, sponsor of | Veterinary Vaccines 2016 Toggle navigation World Veterinary Vaccines Conference 2016 29 - 30 March Grand Hyatt, Washington D.C., USA home our story The big idea invitation from Dr. Poland testimonials VIE awards VIE awards - Nominees sponsor / exhibit why sponsor/exhibit? who should sponsor / exhibit? floor plan sponsors / exhibitors partners sponsor / exhibit now 2015 event report download prospectus agenda why attend? who attends? agenda at a glance speakers cancer & immunotherapy influenza & respiratory emerging & re-emerging diseases clinical … egister Ichor Medical Systems Bronze Sponsor Ichor is dedicated to the clinical application and commercialization of its TriGrid™ electroporation technology for the delivery of nucleic acid based biologics to treat a broad spectrum of disease indications including cancer, chronic viral infections, HIV, ebola and multiple biodefense agents. Ichor has established several ongoing research and development collaborations and licensing agreements to advance the development of its T
syracuse.com - Ichor Life Sciences began out of a... Facebook Log In syracuse.com's Post syracuse.com Verified account May 20, 2024 · Shared with Public Ichor Life Sciences began out of a Tipperary Hill apartment living room in 2013 and has since expanded to three locations in LaFayette and one in Potsdam, Ichor CEO Kelsey Moody said. Now the local biotech company that focuses on fighting age-related diseases is growing once again, moving from LaFayette to downtown Syracuse with the aid of roughly half a million dollars in New York state grants and tax credits. Read the full story: https:
We are excited to announce Dr Kelsey Moody at Longevity Summit Dublin 2023. Tickets are flying! don’t miss this unique opportunity to get the most innovative ground breaking news in the Longevity field. Get your ticket now https://lnkd.in/dAQrHwid Kelsey Moody, PhD, MBA CEO at Ichor Life Sciences, Inc. Process-oriented drug developer and executive who has specialised in the study of aging and aging mechanisms focused on developing treatments for macular degeneration. Macular degeneration is one of the leading causes of vision loss in older adults. He aims to advance novel treatments and techno … cules, antibody mimetics, contract research services and a strategic investment fund. Dr. Moody holds a PhD in biochemistry and molecular biology from University of Miami’s Miller School of Medicine and an MBA in risk management from Concordia University. The LEV Foundation Lifespan.io / Lifespan Extension Advocacy Foundation QuadraScope . Fáilte Ireland . Maxwell Biosciences . Longevity Technology . Ichor Life Sciences, Inc. #maculardegeneration #eyehealth #visioncare #retin
#jpm24 #jpm204 #jpmweek | Ichor Life Sciences, Inc. LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement , Privacy Policy ,
Ichor Life Sciencesinvests $1.5M in Charleston bioscience company - SCbio Skip to content Download the 2026 Economic Impact Report About About SCbio Team SCbio Board of Directors SCbio Office Locations Events Calendar Events at a Glance Life + Science Annual Conference BIO International Convention 2026 Drive Demo Day 2026 Sponsorships Membership Membership Benefits Member Login Complimentary Meeting Space Meet Our Members Students Programs Drive Accelerator Available Lab Space Workforce Development Economic Development Advocacy Entrepreneurship News Industry News Share Your Company News 2026 E
Home - Vitalist Bay 0 % Sponsor Join May 14 – 17 2026 Join Longevity's New Capital VITALIST BAY SIGN UP 100+ speakers Lighthaven, Berkeley. 200+ Companies Four days. 150+ workshops & talks 100+ speakers 18 activities & health tests 2026 Speakers Day 1 THU May 14 Main Investors Replacement Adam Gries Founder Vitalism Carsten Charlesworth Postdoctoral Researcher Stanford University Christine Peterson Co-Founder Foresight Institute Daniel Burger Founder Eightsix Science Derya Unutmaz Professor The Jackson Laboratory Dylan McGuire Founder Aleph Surgical Emil Kendziorra Emil Kendziorra … Verdin President and CEO The Buck Institute Jamie Justice Executive Director X-Prize Healthspan Jarod Rutledge Director of Biotechnology Investments Starbloom Capital Jean Hebert Program Director ARPA-H Kayla Barnes-Lentz Founder The Female Longevity Protocol Kris Borer Angel investor krisborer.com Laura Minquini Founder AthenaBIO Nathan Price Professor & Co-Director, Center for Human Healthspan Buck Institute Omri Amirav-Drory General Partner Nfx Bio Patri Friedman Gene … ti-Retirement Club, Beusail longevity forums Danielle Strachman Co-Founder 1517 Fund Elaine Shi Co-Founder and CEO Bodyspec Eli Berlin Co-Founder, COO and CFO Terray Therapeutics Eric Morgen COO BioAge Hank Greely Professor of Law, Genetics Stanford University Jarod Rutledge Director of Biotechnology Investments Starbloom Capital Justin Rebo CEO Kind Biotechnology Karl Pfleger Founder Aging Biotech Info Kelsey Moody CEO, Founder, Angel Investor Ichor Life Sciences Kevin Caldw … tive Armand Cognetta CEO General Proximity Dave Messina General Partner Pioneer Fund Derya Unutmaz Professor The Jackson Laboratory Eli Mohamad Space Biostasis Coalition Fabian Suchy Co-founder, Scientist Nakauchi Lab, Stanford University Farbood Nivi Founder A-List Gloria Eliott Program Manager ARPA-H Greg Fahy Chief Scientific Officer 21st Century Medicine / Intervene Immune Jamie Heywood CEO & Chairman Alden Scientific Jeff Chen Co-founder & CEO Radicle Science Joh … Grua Chief of Staff · BodySpec Roxana Grunenwald Partner, Cofounder · Dorm Room Fund, Biopunk Pasha Gurevich VP Product · Elo Health Lou Hawthorne CEO · Nanotics Motoshi Hayano Associate Professor & CEO · Tokyo University of Science & ASAGI Labs Chong He Partner at LiveBeyond / Principal Investigator · LiveBeyond.ai Jean Hebert Program Di
Facebook Explore the things you love . Log into Facebook Email or mobile number Password Log in Forgot password? Create new account English (US) فارسی العربية Türkçe Deutsch Français (France) Polski More languages… Sign Up Log In Messenger Facebook Lite Video Meta Pay Meta Store Meta Quest Ray-Ban Meta Meta AI Instagram Threads Privacy Policy Privacy Center About Create ad Create Page Developers Careers Cookies Ad choices Terms Help Contact Uploading & Non-Users Meta © 2026
About Us | Ichor Life Sciences Skip to content Services Protein Services Protein Expression & Purification Services Adeno-Associated Virus (AAV) Structural Biology Services X-Ray Crystallography Services Biophysical Assays Surface Plasmon Resonance Services Biacore Assay Services Circular Dichroism (CD) Assay Services nanoDSF Assay Services Bio-layer Interferometry Services Isothermal Titration Calorimetry Plate-Based Assay Services View All Protein Services Pharmacology Services Drug Discovery Services Drug Development Services Lead Discovery Services Lead Optimization Services High Cont … l school at SUNY Upstate Medical University in Syracuse, NY. Using a $540K seed grant awarded by the Life Extension Foundation, Ichor established a functional laboratory in an apartment living room in historic Tipperary Hill. The living room laboratory was fully equipped for biological research. Initial programs at the company focused on stem cell biology, with capabilities to support mammalian cell culture, flow cytometry, and fluorescence microscopy. Ichor living room lab (
- YouTube Info Presse Urheberrecht Kontakt Creator Werben Entwickler Impressum Verträge hier kündigen Nutzungsbedingungen Datenschutz Richtlinien & Sicherheit Wie funktioniert YouTube? Neue Funktionen testen © 2026 Google LLC
Yesterday I was able to visit... - Congressman John Katko Facebook Log In Congressman John Katko's Post Congressman John Katko Verified account February 13, 2018 · Shared with Public Yesterday I was able to visit Ichor Therapeutics, Inc. with LaFayette Town Supervisor Daniel Fitzpatrick. Ichor Therapeutics is a biotech startup that that specializes in stem cell research, lifespan studies, and drug discovery services. CEO Kelsey Moody and Quality Assurance Director, Scott Campbell talked to us about how tech, research, and startup businesses can thrive in small towns throughout NY-24. All
Ichor's team is enjoying the... - Ichor Life Sciences, Inc. Facebook Log In Ichor Life Sciences, Inc.'s Post Ichor Life Sciences, Inc. August 24, 2023 · Shared with Public Ichor's team is enjoying the RNA Assay Development and Screening Summit in Boston, MA. Stop by our new booth and discuss collaborations or opportunities with our talented scientists! #ichorlifesciences #RNA #drugdiscovery #unconventionalthinking #unprecedenteddoing All reactions: 26 1 comment 2 shares Like Comment Most relevant Annette Deyo Hi Kelsey! 2y
--> About | Ichor Research top of page 315-904-5004 For Patients Welcome Evaluations and Screening FAQ Current Studies For Sponsors Welcome Our Model Hepatic & Metabolic Neuro and CNS Contact Us About More Use tab to navigate through the menu items. Where Quality Data Meets Real Patient Care Our leadership team comes with first-hand experience on the Sponsor side, CRO Services, and in clinical trial site operations. With an understanding of the unique challenges facing each team involved in executing a trial, we seek to be a collaborator and partner to every stakeholder, from the Sponsor t
Cypris Therapeutics Launches as Newest Ichor Life Sciences Portfolio Company, Secures Over $500k in Pre-Seed Funding - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Pharm Country Cypris Therapeutics Launches as Newest Ichor Life Sciences Portfolio Company, Secures Over $500k in Pre-Seed Funding June 24, 2024 | 2 min read Twitter LinkedIn Facebook Email Print Cypris Therapeutics, a drug discovery company, has launched following a breakthrough in synthetic chemistry technology which … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Ichor Life Sciences Invests $1.5 Million in MitoChem Therapeutics for Ocular Aging Disease Research - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Pharm Country Ichor Life Sciences Invests $1.5 Million in MitoChem Therapeutics for Ocular Aging Disease Research August 15, 2022 | 3 min read Twitter LinkedIn Facebook Email Print Ichor Life Sciences, a preclinical contract research organization, announced a $1.5 million investment in MitoChem Therapeutics. LAFAYETTE, … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
CRO Services | Ichor Life Sciences Skip to content Services Protein Services Protein Expression & Purification Services Adeno-Associated Virus (AAV) Structural Biology Services X-Ray Crystallography Services Biophysical Assays Surface Plasmon Resonance Services Biacore Assay Services Circular Dichroism (CD) Assay Services nanoDSF Assay Services Bio-layer Interferometry Services Isothermal Titration Calorimetry Plate-Based Assay Services View All Protein Services Pharmacology Services Drug Discovery Services Drug Development Services Lead Discovery Services Lead Optimization Services High
PhD Programs | Ichor Life Sciences Skip to content Services Protein Services Protein Expression & Purification Services Adeno-Associated Virus (AAV) Structural Biology Services X-Ray Crystallography Services Biophysical Assays Surface Plasmon Resonance Services Biacore Assay Services Circular Dichroism (CD) Assay Services nanoDSF Assay Services Bio-layer Interferometry Services Isothermal Titration Calorimetry Plate-Based Assay Services View All Protein Services Pharmacology Services Drug Discovery Services Drug Development Services Lead Discovery Services Lead Optimization Services High … Tuition Waiver All students receive tuition waivers paid for by Ichor. Research Stipend All students receive a monthly stipend commensurate with NIH ITRA level. Training All students receive robust didactic and laboratory training in diverse disciplines. Eligibility Requirements All applicants must meet the outlined eligibility criteria to be considered. Employees who plan to pursue a PhD at Ichor should notify management as early as possible. Employee training will be adjust … oyee training will be adjusted and coaching provided to prepare the employee to apply and succeed within the program. Minimum 12 months continuous employment at Ichor. BS/BA in the life sciences from an accredited university. 3.5+ GPA or compensatory research experience (can be completed at Ichor). Prerequisites for selected program as outlined by university partner. Exceptional grit, emotional IQ, openness, and resiliency. Who is an ideal candidate? Our PhD program combines
Job Openings | Ichor Life Sciences Skip to content Services Protein Services Protein Expression & Purification Services Adeno-Associated Virus (AAV) Structural Biology Services X-Ray Crystallography Services Biophysical Assays Surface Plasmon Resonance Services Biacore Assay Services Circular Dichroism (CD) Assay Services nanoDSF Assay Services Bio-layer Interferometry Services Isothermal Titration Calorimetry Plate-Based Assay Services View All Protein Services Pharmacology Services Drug Discovery Services Drug Development Services Lead Discovery Services Lead Optimization Services High … penings Come join our dynamic team today! Open Positions Position Location Type Apply Research Scientist Syracuse, NY (Onsite) Full-time Apply Research Associate I - Discovery Syracuse, NY (Onsite) Full-time Apply Research Associate I - Pharmacology Syracuse, NY (Onsite) Full-time Apply Research Technician I - Discovery Syracuse, NY (Onsite) Full-time Apply Your Secret Weapon for Drug R&D [email protected] Contact Us If you are a patient volunteer, please call (3